Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. (Q54566271)

From Wikidata

Revision as of 01:44, 13 June 2019 by Cavernia (talk | contribs) (‎Removed claim: author name string (P2093): B T Gjertsen, #quickstatements; #temporary_batch_1560374258811)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

Per Eystein Lønning

10

object named as

P E Lønning

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

Stian Knappskog

9

object named as

S Knappskog

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

Bjørn Tore Gjertsen

12

object named as

B T Gjertsen

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

author name string

N Ånensen

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

S M Hjelle

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

W Van Belle

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

I Haaland

4

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

E Silden

5

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

J-C Bourdon

6

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

R Hovland

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

K Taskén

8

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

Ø Bruserud

11

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

publication date

22 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

31

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

12

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

1533-1545

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

p53 isoforms can regulate p53 transcriptional activity.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

p53 isoform delta113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Control of apoptosis by p53.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Nucleophosmin and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Assessing p53 in clinical contexts: unlearned lessons and new perspectives

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Single cell profiling of potentiated phospho-protein networks in cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Identification of Ki23819, a highly potent inhibitor of kinase activity of mutant FLT3 receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

The first 30 years of p53: growing ever more complex

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Study of suboptimum treatment response: lessons from breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

An integrated genomic analysis of human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Drug therapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

p53 in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.348

21 January 2018

Identifiers

10.1038/ONC.2011.348

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/21860418

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54566271&oldid=961142081"